Immunogenicity and Protective Ability of Genotype I-Based Recombinant Japanese Encephalitis Virus (JEV) with Attenuation Mutations in E Protein against Genotype V JEV

Genotype V (GV) Japanese encephalitis virus (JEV) has emerged in Korea and China since 2009. Recent findings suggest that current Japanese encephalitis (JE) vaccines may reduce the ability to induce neutralizing antibodies against GV JEV compared to other genotypes. This study sought to produce a no...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajima, Shigeru, Taniguchi, Satoshi, Nakayama, Eri, Maeki, Takahiro, Inagaki, Takuya, Saijo, Masayuki, Lim, Chang Kweng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538582/
https://www.ncbi.nlm.nih.gov/pubmed/34696184
http://dx.doi.org/10.3390/vaccines9101077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538582/
https://www.ncbi.nlm.nih.gov/pubmed/34696184
http://dx.doi.org/10.3390/vaccines9101077

Ejemplares similares